These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35881225)

  • 41. Polypharmacy and Deprescribing in Older Adults.
    Thompson W; McDonald EG
    Annu Rev Med; 2024 Jan; 75():113-127. PubMed ID: 37729029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-Effectiveness of Antihypertensive Deprescribing in Primary Care: a Markov Modelling Study Using Data From the OPTiMISE Trial.
    Jowett S; Kodabuckus S; Ford GA; Hobbs FDR; Lown M; Mant J; Payne R; McManus RJ; Sheppard JP;
    Hypertension; 2022 May; 79(5):1122-1131. PubMed ID: 35266409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug Prescribing: Polypharmacy and Deprescribing.
    McQuade BM; Campbell A
    FP Essent; 2021 Sep; 508():33-40. PubMed ID: 34491710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deprescribing versus continuation of chronic proton pump inhibitor use in adults.
    Boghossian TA; Rashid FJ; Thompson W; Welch V; Moayyedi P; Rojas-Fernandez C; Pottie K; Farrell B
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011969. PubMed ID: 28301676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy.
    Omuya H; Nickel C; Wilson P; Chewning B
    Int J Pharm Pract; 2023 Jun; 31(4):349-368. PubMed ID: 37155330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deprescribing Medications Among Older Adults From End of Hospitalization Through Postacute Care: A Shed-MEDS Randomized Clinical Trial.
    Vasilevskis EE; Shah AS; Hollingsworth EK; Shotwell MS; Kripalani S; Mixon AS; Simmons SF
    JAMA Intern Med; 2023 Mar; 183(3):223-231. PubMed ID: 36745422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic Polypharmacy with Increasing Drug Burden Index Exacerbates Frailty and Impairs Physical Function, with Effects Attenuated by Deprescribing, in Aged Mice.
    Mach J; Gemikonakli G; Logan C; Vander Wyk B; Allore H; Ekambareshwar S; Kane AE; Howlett SE; de Cabo R; Le Couteur DG; Hilmer SN
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1010-1018. PubMed ID: 32147704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors which influence the deprescribing decisions of community-living older adults and GPs in Australia.
    Gillespie R; Mullan J; Harrison L
    Health Soc Care Community; 2022 Nov; 30(6):e6206-e6216. PubMed ID: 36165345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Short-term effect of deprescribing antihypertensives in older people.
    Morselli F; Khong TK
    Drug Ther Bull; 2022 Aug; 60(8):118-119. PubMed ID: 35710539
    [No Abstract]   [Full Text] [Related]  

  • 50. Prescribing and deprescribing in very old age: perceptions of very old adults, caregivers and health professionals.
    Ouellet N; Bergeron AS; Gagnon E; Cossette B; Labrecque CA; Sirois C
    Age Ageing; 2022 Nov; 51(11):. PubMed ID: 36413585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deprescribing: a new goal focused on the patient.
    Machado-Alba JE; Gaviria-Mendoza A; Machado-Duque ME; Chica L
    Expert Opin Drug Saf; 2017 Feb; 16(2):111-112. PubMed ID: 27984921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Role of Deprescribing in Older Adults with Chronic Kidney Disease.
    Triantafylidis LK; Hawley CE; Perry LP; Paik JM
    Drugs Aging; 2018 Nov; 35(11):973-984. PubMed ID: 30284120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
    Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
    Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. GPs' mindlines on deprescribing antihypertensives in older patients with multimorbidity: a qualitative study in English general practice.
    Kuberska K; Scheibl F; Sinnott C; Sheppard JP; Lown M; Williams M; Payne RA; Mant J; McManus RJ; Burt J
    Br J Gen Pract; 2021 Jul; 71(708):e498-e507. PubMed ID: 34001537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deprescribing research in nursing home residents using routinely collected healthcare data: a conceptual framework.
    Thorpe C; Niznik J; Li A
    BMC Geriatr; 2023 Aug; 23(1):469. PubMed ID: 37542226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
    Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
    Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combating Polypharmacy Through Deprescribing Potentially Inappropriate Medications.
    Chou J; Tong M; Brandt NJ
    J Gerontol Nurs; 2019 Jan; 45(1):9-15. PubMed ID: 30653232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deprescribing in older patients by early-career general practitioners: Prevalence and associations.
    Magin P; Quain D; Tapley A; van Driel M; Davey A; Holliday E; Ball J; Kaniah A; Turner R; Spike N; FitzGerald K; Hilmer S
    Int J Clin Pract; 2021 Aug; 75(8):e14325. PubMed ID: 33960089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deprescribing as a Clinical Improvement Focus.
    Dharmarajan TS; Choi H; Hossain N; Munasinghe U; Lakhi F; Lourdusamy D; Onuoha S; Murakonda P; Skokowska-Lebelt A; Kanagala M; Russell RO
    J Am Med Dir Assoc; 2020 Mar; 21(3):355-360. PubMed ID: 31672564
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Issues with deprescribing in haemodialysis: a qualitative study of patient and provider experiences.
    Bondurant-David K; Dang S; Levy S; Sperlea D; Vanier MC; Gerardi S; David PM
    Int J Pharm Pract; 2020 Dec; 28(6):635-642. PubMed ID: 33094884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.